Doctor Profile

ABOUT DR. VIKRANT B. GHATNATTI

An MBBS, MD in General Medicine and DM in Endocrinology, Dr. Vikrant Ghatnatti has done numerous research work, presentations and publications. Dr. Vikrant Ghatnatti specializes in diagnosing, evaluating and treating patients in Diabetes, Thyroid Disorders and other Hormonal Disorders like Short Stature, Adrenal and Pituitary Disorders, Metabolic Disorders etc. With years of experience Dr. Vikrant Ghatnatti has established himself as a leading consultant of Endocrinology and successfully runs his own Endocrine Centre.

Apart from running his own hospital Dr. Vikrant Ghatnatti has been associated with various Hospitals as consultant and with colleges and institutes as a visiting faculty. Being an M.D and D.M. of Endocrinology Dr. Vikrant Ghatnatti specializes in Diabetes care, Thyroid Disorders and others.

Over a period of time with several awards and achievements and by attending and organizing many seminars and CMEs; Dr. Vikrant Ghatnatti has carved a permanent niche for himself in by working for the society. Dr. Vikrant Ghatnatti has participated in various seminars, carried out various education programs to spread mass education about the prevention and cure of diabetes. Dr. Vikrant Ghatnatti is also an astute learner, a keen observer and has a passion for teaching.

ACADEMIC QUALIFICATION

  • M.B.B.S
  • MD General Medicine
  • DM (Endocrinology)

SKILLS

  • Have mastered skills in diagnosing, evaluating and treating patients in diabetes, thyroid disordes, short stature, adrenal and pituitary disorders , metabolic disorders.
  • An astute learner and a keen observer with passion for teaching

TEAM WORK

Have volunteered in organising a Continuing Medical Education Programme by Department of General Medicine, Jawaharlal Nehru Medical College , in the year 2009.

CURRICULUM VITAE

Dr VIKRANT GHATNATTI

MD (General Medicine) DM (Endocrinology)
DM (Endocrinology) (2014)
Gauhati Medical College, Guwahati, ASSAM
MD General Medicine (2009)
Jawaharlal Nehru Medical College Belgaum, Karnataka
M.B.B.S (2005)
Jawaharlal Nehru Medical College Belgaum, Karnataka
PRESNTLY WORKING AS
  • CONSULTANT ENDOCRINOLOGIST AND HEAD, DEPT OF ENDOCRINOLOGY, KLE’S DR PRABHAKAR KORE HOSPITAL AND RESEARCH CENTRE, BELGAUM
  • ASSISTANT PRIOFESSOR, JAWAHARLAL NEHRU MEDICAL COLLEGE, BELGAUM
  • CONSULTANT DIABETOLOGIST AND ENDOCRINOLOGIST, GHATNATTI ENDOCRINE CENTRE, BELAGAVI

MEMBER:

  • ENDOCRINE SOCIETY OF INDIA
  • AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGIST

Acheivements & Awards

  • Awarded “DR PRABHAKAR KORE GOLD MEDAL” IN MEDICINE for securing highest marks in postgraduate medicine exam.
  • Received “BEST OUTGOING POSTGRADUATE IN MEDICINE AWARD” from Jawaharlal Nehru Medical College, Belgaum, Karnataka in 2009.
  • FIRST PRIZE in National level MEDICAL QUIZ held at APICON 2009 at Greater Noida, and was awarded
  • FIRST PRIZE in zonal undergraduate pediatric quiz conducted by IAP at MRMC, Gulbarga in 2004
  • SECOND PRIZE in case report podium presentation at ASSSAM ENDOCRINE SOCIETY CONFERENCE on 12th April 2014
  • Participated in various National, State and Regional conferences and CME’s.
  • Participated in a course on Clinical Research Workshop and ICH-GCP Guidelines in July, 2008 conducted by Centre for Advanced Medical Sciences (CAMS) of KLES Dr. Prabhakar Kore Hospital and Medical Research Centre, Belgaum (India).
  • Participated in the Workshop on BIOSTATISTICS AND THYROID ULTRASOUND at ESICON 2013 held at KOLKOTA.

ACADEMIC ACTIVITIES

Editor of Endocrine Update -2014 published by ASSAM ENDOCRINE SOCIETY

INTERNATIONAL PUBLICATIONS: 1

  1. Endogenous Cushing’s and Grave’s disease in a patient with prolonged steroid intake – A diagnostic dilemma. International journal of clinical cases and investigations. May 2014

NATIONAL PUBLICATIONS:

  1. Empty sella syndrome – beyond being an incidental finding .IJEM Dec, 2013
  2. Enlarged hands and feet- not always acromegaly. IJEM Dec, 2013

NATIONAL PRESENTATIONS:

  1. Clinical profile of childhood Graves Disease- an experience from the north east. ITSCON, 2013 BANGALORE
  2. FNAC versus USG in the management of solitary thyroid nodule. THYROID UPDATE – 2013, KOLKOTA
  3. Simultaneous Grave’s disease and Cushing’s syndrome – a case report. Assam Endocrine Society conference 2014.

OTHERS:

SPEAKER AND CHAIRPERSON AT VARIOUS INTERNATIONAL, NATIONAL, STATE AND REGIONAL LEVEL CONFERENCES.

SPEAKER IN INTER-NATIONAL, NATIONAL and STATE CONFERENCES AND CME:

  1. “The art and science of insulin” at DIABETES UPDATE 2014 at KIMS- HUBBALI on 15th November 2014
  2. “Fighting the obesity epidemic: Need of the hour” at APPI National seminar 2015
  3. “Anesthesia for patients with endocrine disorders” at CME in ANAESTHESIOLOGY on 22nd August 2015
  4. “Bone mineral metabolism” at World OSTEOPOROSIS DAY CME on 20th October 2015
  5. “New paradigm in diabetes management” at Annual conference 2015, IMA HUBBALI
  6. “SGLT2 inhibitors in diabetes management” at DIABETES UPDATE 2015 by IMA HUBBALI
  7. “Emerging challenges in medical practice” at JNMC SCIENTIFIC SOCIETY ANNUAL CME-2015
  8. “Newer challenges in managing diabetes” at DIACON-2015
  9. “Laboratory errors” at JNMC AMBKCON-2016 on 24th September 2016.
  10. “Management of Hyperthyroidism” at 19th SURTGERY CME 2015 ON 17th October 2016
  11. Speaker at annual endocrine meet KESICON 2017, Bangalore
  12. Speaker at DIACON 2016, Bagalkot
  13. Speaker at Dublin University metabolic symposium at Dublin, Ireland.
  14. “Hormonal evaluation in reproductive endocrinology” at IMA Belagavi in sept 2018
  15. “diabetes in young” at KESICON, Bangalore in Nov,2018
  16. Speaker at National ESI YUVA ENDOCRINOLOGY meet at Goa, October 2019.
  17. ” Medical Management of Osteoporosis” at orthopaedic CME in Belagavi , 2019

WORKSHOPS CONDUCTED:

Workshop on “Training on Health promotion” at DOME, KLE UNIVERSITY on 6th November 2015

CHAIRPERSON AT KRSSDI 2015, KESICON 2017

MEMBER

  1. ENDOCRINE SOCIETY OF INDIA
  2. AMERICAN SOCIETY OF ENDOCRINOLOGISTS
  3. INDIAN THYROID SOCIETY
  4. KARNATAKA ENDOCRINE SOCIETY
  5. ASSAM ENDOCRINE SOCIETY

PUBLICATIONS:

TITLE CITED BY YEAR
Empty sella syndrome–beyond being an incidental finding
V Ghatnatti, D Sarma, U Saikia
Indian journal of endocrinology and metabolism 16 (Suppl 2), S321
27 2012
Enlarged hands and feet–Not always acromegaly
V Ghatnatti, D Sarma, U Saikia
Indian journal of endocrinology and metabolism 16 (Suppl 2), S318
3 2012
Awareness of gestational diabetes mellitus among pregnant women attending a tertiary health center
V Dhyani, NS Mahantashetti, MS Ganachari, S Kambar, V Ghatnatti
Indian Journal of Health Sciences and Biomedical Research (KLEU) 11 (1), 51
2 2018
Sodium glucose co-transporter-2 inhibitor: Benefits beyond glycemic control
MP Baruah, BM Makkar, VB Ghatnatti, K Mandal
Indian journal of endocrinology and metabolism 23 (1), 140
1 2019
Isolated premature thelarche: A normal growth variant
PR Inamdar, RM Bellad, VR Herekar, MR Sarvi, VB Ghatnatti, HA Shah
Journal of the Scientific Society 44 (2), 114
1 2017
Travesty of a thyroglossal cyst–A clinical scenario
BP Belaldavar, VB Ghatnatti, MR Bhat
Thyroid Research and Practice 16 (2), 80
  2019
Nerve conduction abnormalities in patients with newly diagnosed diabetes mellitus
AP Kulkarni, AO Saroja, KR Naik, V Ghatnatti, N Hesarur
Journal of the Scientific Society 45 (1), 30
  2018
Clinical Profile of Brucellosis–A Cross-Sectional Study
V Ghatnatti
KLE University, Belagavi, Karnataka
   

RESEARCH WORK

  1. Principal investigator : A Phase 3, Randomized, Double-Blind, Parallel-Group, Vehicle Controlled, Multicenter Study Of The Efficacy And Safety Of Granexin Gel In The Treatment Of Diabetic Foot Ulcer.
  2. Principal investigator : A randomized,24-week, controlled open label, parallel arm, multicenter study comparing the safety and efficacy of insulin glargine/lixisenatide fixed ratio combination to insulin glargine in type 2 diabetes patients, inadequately controlled on basal insulin with or without metformin.
  3. Principal investigator: A multi-centre prospective, non-interventional study of ability and willingness to pay for BIAsp 30 in a real world population with type 2 diabetes mellitus”.